Clinical Trials
3 trialsNCT00083941 2020-10-19
A Study of TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell Cancer
Oxford BioMedica
Phase 2 Completed
NCT00325507 2020-10-19
Safety and Biological Activity of TroVax® Vaccine Given With IL-2 in Renal Cell Carcinoma
Oxford BioMedica
Phase 2 Completed
NCT00397345 2020-10-19
TroVax Renal Immunotherapy Survival Trial
Oxford BioMedica
Phase 3 Completed